Foresters Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Foresters Investment Management's BMY Position: Q3 2019 in Review
Foresters Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2019, selling an estimated $834K and leaving 90,300 shares worth $4.58M. The position accounts for 0.09% of the portfolio, ranked #262.
Foresters Investment Management first reported a position in BMY in Q2 2017 and has held it in 8 quarters since. The position peaked at $19.2M in Q4 2018. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.
- Foresters Investment Management held 90,300 shares of Bristol-Myers Squibb worth $4.58M as of Q3 2019.
- Foresters Investment Management sold 17,750 Bristol-Myers Squibb shares in Q3 2019, an estimated $834K.
- Bristol-Myers Squibb made up 0.09% of Foresters Investment Management's portfolio in Q3 2019, its #262 holding.
- Foresters Investment Management first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 8 quarters since.
- Foresters Investment Management's Bristol-Myers Squibb position peaked at $19.2M in Q4 2018.
- 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.
Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.